Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Cd44 Epithelial Isoform Inversely Associates With Invasive Characteristics of Colorectal Cancer Publisher Pubmed



Sadeghi A1 ; Roudi R1 ; Mirzaei A2 ; Zare Mirzaei A3 ; Madjd Z1, 4 ; Abolhasani M1, 5
Authors

Source: Biomarkers in Medicine Published:2019


Abstract

Aim: There is no consensus regarding the clinical significance of CD44 and CD24 as cancer stem cell (CSC) marker in colorectal cancer (CRC). Methodology: A total of 494 CRC samples (2008-2017) were assessed for CD44 (epithelial isoform) and CD24 expression using tissue microarray. Results: CD24 individually or in combination with CD44 was not associated with any of the clinicopathologic characteristics of the tumor. CD44 expression was inversely associated with pathological Tumor, Node, Metastasis (pTNM) lower stages (p = 0.038) and lymphatic invasion (p = 0.05). Conclusion: In summary, the epithelial isoform of CD44 is inversely associated with invasive characteristics of CRC. © 2019 Future Medicine Ltd.
Related Docs
View other Related Docs
1. Co-Expression of Putative Cancer Stem Cell Markers Cd44 and Cd133 in Prostate Carcinomas, Pathology and Oncology Research (2017)
2. Lgr5 High /Dclk1 High Phenotype Is More Common in Early Stage and Intestinal Subtypes of Gastric Carcinomas, Cancer Biomarkers (2017)
3. Expression of Cancer Stem Cell Markers Oct4 and Cd133 in Transitional Cell Carcinomas, Applied Immunohistochemistry and Molecular Morphology (2017)
Experts (# of related papers)
View all Related Experts
Gholamreza Tavoosidana (2)
Vahid Salimi (2)
Other Related Docs
4. A New Insight Into Cancer Stem Cell Markers: Could Local and Circulating Cancer Stem Cell Markers Correlate in Colorectal Cancer?, Tumor Biology (2016)
5. Evaluation of Circulating Cellular Dclk1 Protein, As the Most Promising Colorectal Cancer Stem Cell Marker, Using Immunoassay Based Methods, Cancer Biomarkers (2016)
6. Expression Patterns and Clinical Significance of the Potential Cancer Stem Cell Markers Oct4 and Nanog in Colorectal Cancer Patients, Molecular and Cellular Oncology (2020)
7. Increased Expression of Cd44 Is Associated With More Aggressive Behavior in Clear Cell Renal Cell Carcinoma, Biomarkers in Medicine (2018)
8. Involvement of Cd24 in Multiple Cancer Related Pathways Makes It an Interesting New Target for Cancer Therapy, Current Cancer Drug Targets (2018)
9. High Gd2 Expression Defines Breast Cancer Cells With Enhanced Invasiveness, Experimental and Molecular Pathology (2019)
10. Cancer Stem Cell Research in Iran: Potentials and Challenges, Future Oncology (2017)
11. Verification of Aldh Activity As a Biomarker in Colon Cancer Stem Cells-Derived Ht-29 Cell Line, International Journal of Cancer Management (2015)
12. Cd44 and Cd74: The Promising Candidates for Molecular Targeted Therapy in Oral Squamous Cell Carcinoma, Dental Research Journal (2015)
13. Nano-Delivery System Targeting to Cancer Stem Cell Cluster of Differentiation Biomarkers, Journal of Controlled Release (2017)
14. Increased Expression of Aldh1a1 in Prostate Cancer Is Correlated With Tumor Aggressiveness: A Tissue Microarray Study of Iranian Patients, Applied Immunohistochemistry and Molecular Morphology (2017)
15. Clinicopathological Significance of Tumor Stem Cell Markers Aldh1 and Cd133 in Colorectal Carcinoma, Iranian Journal of Pathology (2021)
16. Morphological and Molecular Characteristics of Spheroid Formation in Ht-29 and Caco-2 Colorectal Cancer Cell Lines, Cancer Cell International (2021)
17. The Local and Circulating Sox9 As a Potential Biomarker for the Diagnosis of Primary Bone Cancer, Journal of Bone Oncology (2020)
18. Microrna Expression Levels and Histopathological Features of Colorectal Cancer, Journal of Gastrointestinal Cancer (2019)
19. Expression Patterns of Cxcl12 and Its Receptor in Colorectal Carcinoma, Clinical Laboratory (2018)
20. Evaluation of the Local and Circulating Expression Level of Cannabinoid Receptor 2 in Patients With Lung Cancer, Gene Reports (2022)